To this end, ONECUT2 was shown to act as suppressor of AR activity and to directly activate PEG10 thus supporting the central role of ONECUT2 in the transition from adenocarcinoma to NEPC [70]. The gene discussed is ONECUT2; the disease is adenocarcinoma.